Viewing Study NCT04276233


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-01-01 @ 4:45 AM
Study NCT ID: NCT04276233
Status: COMPLETED
Last Update Posted: 2024-12-10
First Post: 2020-02-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma
Sponsor: GlaxoSmithKline
Organization: